Objective To prepare controlled porosity osmotic pump tablets of sodium salicylate.
目的制备水杨酸钠渗透泵控释片。
Objective To prepare osmotic pump controlled release tablets of isosorbide mononitrate.
目的制备单硝酸异山梨酯渗透泵控释片。
The invention provides a doxazosin mesylate bi-layer osmotic pump controlled release tablet.
本发明提供了一种甲磺酸多沙唑嗪双层渗透泵控释片。
OBJECTIVE to prepare the tolterodine osmotic pump tablet and study its release profiles in vitro.
目的制备酒石酸托特罗定渗透泵片，考察其体外释药特性。
Corrosion mechanism and diffusion mechanism have effect on drug release from osmotic pump tablets.
扩散与溶蚀机制对渗透泵片释药有影响。
Objective to introduce a method of chronic infusion of drugs into the cochlea using a osmotic pump.
目的介绍微型渗透压泵进行耳蜗灌注的方法，达到耳蜗慢性给药。
Objective: To study the in vitro release rate of ambroxol HCl osmotic pump controlled release tablets.
前言：目的：研究盐酸氨溴索渗透泵控释片的体外释放度。
Methods:The release rate of ambroxol HCl osmotic pump controlled release tablets in various mediums was observed.
方法：考察渗透泵在不同介质中的释放情况。
Results:Preparation of Huangyangning osmotic pump controlled release tablets in vitro release rate of more stable.
结果：制备的黄杨宁渗透泵控释片体外释药速度较平稳。
Our research in osmotic pump formulations will start from two aspects, the core prescription and the coating film.
我们对渗透泵型控释制剂的研究，从包衣膜和片芯处方两个方面着手。
OBJECTIVE To develop a simplified preparative method for osmotic pump tablet using prazosin hydrochloride as a model drug.
目的以盐酸哌唑嗪为模型药物研究单层芯渗透泵片简化的制备方法。
Aim To prepare ondansetron hydrochloride osmotic pump tablets (OND-OPT) and investigate their in vitro drug release behavior.
目的制备盐酸昂丹司琼渗透泵型控释片剂(OND - OPT)并考察体外释药特性。
Objective: to introduce an improved technique of chronic infusion of drugs into the guinea pig cochlea using an osmotic pump.
目的：介绍应用改进的微渗透压泵进行豚鼠耳蜗慢性灌注的方法。
Results: The release rate of ambroxol hydrochloride osmotic pump controlled release tablets prepared was conformed to requirement.
结果：制得的盐酸氨溴索渗透泵控释片释放度符合要求。
Conclusions: The ambroxol HCl osmotic pump controlled release tablets have a stable release curve and conform to zero release order.
结论：盐酸氨溴索渗透泵控释片释药稳定，零级释药明显，具备优良控释制剂的特征。
The technology of the invention can ensure that the prepared two-layer osmotic pump controlled release tablet has good bioavailability.
该技术可以确保制备的双层渗透泵控释片具有良好的生物利用度。
CONCLUSION it was feasible to enhance the soluble ability and prepare the monolithic osmotic pump tablet of atenolol with tartaric acid.
结论用酒石酸提高阿替洛尔的溶解能力并进而制备单层芯渗透泵片的方法是可行的。
Objective To prepare controlled release tablets of matrine, and establish a new method for preparation of elementary osmotic pump tablets.
目的制备苦参碱渗透泵型控释片，同时建立一种新的设计初级渗透泵处方的方法。
OBJECTIVE to improve the drug release reproducibility of elementary osmotic pump tablets and to investigate its drug release mechanism with a new method.
目的研究渗透泵型控释片剂的释药规律及释药重现性，探索考察释药机制的新方法。
Conclusion The drug release of sodium ferulate single-layer osmotic pump controlled release tablets is stable and had obvious characteristic of zero release.
结论阿魏酸钠单层渗透泵控释片工艺稳定，呈明显的零级释药特征。
The drilling requirements in the production of a new type troche, osmotic pump control-released tablets, is the nodus in the research of this kind of medicine.
新剂型“渗透泵控释片剂”生产中的打孔要求是目前该类型制剂的研发瓶颈。
RESULTS The influx of water that passed the osmotic pump tablet was greatly less than the drug dissolution rate from tablet core and the bergenin release rate.
结果水透膜的速率远小于片芯中药物的溶出速率及岩白菜素渗透泵片的释药速率；
CONCLUSION plasma concentrations of sodium ferulate porosity osmotic pump tablets are constant and effective plasma drug concent-ration is kept for a long time.
结论阿魏酸钠微孔渗透泵片血药浓度平稳，可较长时间保持血药浓度。
The invention relates to the drug preparation field, in particular to a two-layer osmotic pump controlled release tablet preparation and a preparation method thereof.
本发明涉及药物制剂领域，具体涉及双层渗透泵控释片制剂及其制备方法。
Conclusion: Due to the homoion effect, the release of propranolol hydrochloride from osmotic pump tablets can be influenced by the chloridion in medium or tablet core.
结论：由于同离子效应，释放介质及片芯中的氯离子对盐酸普萘洛尔从渗透泵片中的释放存在较大的影响。
Conclusions: the osmotic pump tablets conform to zero release order in 14 hours, and within the following dose reduction in osmotic pump, the release rate has declined.
结论：本制剂在14h内呈现良好的零级释药特征，此后随渗透泵内药量的减少，释放速度有所下降。
The main processes of the drug delivery of oral osmotic pump system were studied to investigate its delivery characteristics, with verapamil hydrochloride as the model drug.
以盐酸维拉帕米为模型药物，制备了口服渗透泵片。通过考察渗透泵片体外释药各过程的速率，研究口服渗透泵制剂释药的基本过程及其特性。
Compared with the commercialized push pull osmotic pump tablet, sandwiched osmotic pump tablet is easy in preparation with exempting identification of drug layer before drilling.
与市售双层渗透泵片相比，夹芯渗透泵片免去了打孔前的药物层辨认过程，制备过程简化。
The invention also includes capsules, soft capsules, controlled-release capsule, osmotic pump capsules or other proper types of preparation which are prepared through the medicine combination.
本发明也包括利用该药物组合物制备的硬胶囊、软胶囊、缓控释胶囊、渗透泵型胶囊或其他合适的剂型。
The invention also includes capsules, soft capsules, controlled-release capsule, osmotic pump capsules or other proper types of preparation which are prepared through the medicine combination.
本发明也包括利用该药物组合物制备的硬胶囊、软胶囊、缓控释胶囊、渗透泵型胶囊或其他合适的剂型。
应用推荐